Markets
JNJ

J&J Opioid Ruling 2019: 13 Things to Know

The J&J opioid ruling 2019 for the case in Oklahoma has been decided.

Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation

Source: Sundry Photography / Shutterstock.com

Here’s what to know about this ruling for Johnson & Johnson (NYSE:).

  • However, it also wasn’t near as harsh as it could have been.
  • This is far from the $17 billion that the state was hoping to get from the lawsuit.
  • A lawyer for J&J says that the company is already planning to appeal the decision.
  • His decision found that J&J has broken the state’s “public nuisance” law.
  • The company isn’t out of the woods just yet. There are over 2,000 lawsuits in connection to opioids across the U.S.
  • Oklahoma Attorney General Mike Hunter says that he believes companies selling opioids knew of the dangers of the drug before selling them.

You can follow links to learn more about the J&J opioid ruling 2019.

JNJ stock was up 2% as of noon Tuesday.

As of this writing, William White did not hold a position in any of the aforementioned securities.

The post appeared first on InvestorPlace.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

JNJ TEVA

Latest Markets Videos

    InvestorPlace

    InvestorPlace is one of America’s largest, longest-standing independent financial research firms. Started over 40 years ago by a business visionary named Tom Phillips, we publish detailed research and recommendations for self-directed investors, financial advisors and money managers.

    Learn More